REFERENCES
1. Engelen M, Kemp S, de Visser M, et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 2012;7:51.
2. Stone RT, van Haren K. Natural history of brain lesions in X-linked adrenoleukodystrophy: on-again, off-again. Neurology 2020;94:1058-9.
3. Bezman L, Moser AB, Raymond GV, et al. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 2001;49:512-7.
5. Cappa M, Bizzarri C, Vollono C, Petroni A, Banni S. Adrenoleukodystrophy. Endocr Dev 2011;20:149-60.
6. Mahmood A, Raymond GV, Dubey P, Peters C, Moser HW. Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study. Lancet Neurol 2007;6:687-92.
7. Raymond GV, Aubourg P, Paker A, et al. Survival and functional outcomes in boys with cerebral adrenoleukodystrophy with and without hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2019;25:538-48.
8. Mallack EJ, Turk BR, Yan H, et al. MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: meta-analysis and consensus guidelines. J Inherit Metab Dis 2021;44:728-39.
9. Moser HW, Mahmood A, Raymond GV. X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 2007;3:140-51.
10. Loes DJ, Hite S, Moser H, et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994;15:1761-6.
11. Moser HW, Raymond GV, Lu SE, et al. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo’s oil. Arch Neurol 2005;62:1073-80.
12. Miller W. Stem cell-transplantation therapy for adrenoleukodystrophy: current perspectives. J Neurorestoratology 2017;5:5-19.
13. Bessey A, Chilcott JB, Leaviss J, Sutton A. Economic impact of screening for X-linked adrenoleukodystrophy within a newborn blood spot screening programme. Orphanet J Rare Dis 2018;13:179.
14. Beckmann NB, Miller WP, Dietrich MS, Orchard PJ. Quality of life among boys with adrenoleukodystrophy following hematopoietic stem cell transplant. Child Neuropsychol 2018;24:986-98.
15. van den Broek BTA, Page K, Paviglianiti A, et al. Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies. Blood Adv 2018;2:49-60.
16. Lee TY, Li CC, Liaw JJ. The lived experience of Taiwanese mothers of a child diagnosed with adrenoleukodystrophy. J Health Psychol 2014;19:195-206.
17. Kuratsubo I, Suzuki Y, Shimozawa N, Kondo N. Parents of childhood X-linked adrenoleukodystrophy: high risk for depression and neurosis. Brain Dev 2008;30:477-82.
18. Chevalier J, de Pouvourville G. Valuing EQ-5D using time trade-off in France. Eur J Health Econ 2013;14:57-66.
19. RAND Corporation. 36-item short form survey from the RAND medical outcomes study. Available from: https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form.html [Last accessed 3 Jan 2020].
20. van Geel B, Assies J, Haverkort E, et al. Delay in diagnosis of X-linked adrenoleukodystrophy. Clin Neurol Neurosurg 1993;95:115-20.
21. Haren K, Bonkowsky JL, Bernard G, et al; GLIA Consortium. Consensus statement on preventive and symptomatic care of leukodystrophy patients. Mol Genet Metab 2015;114:516-26.
22. Namkung EH, Song J, Greenberg JS, Mailick MR, Floyd FJ. The relative risk of divorce in parents of children with developmental disabilities: impacts of lifelong parenting. Am J Intellect Dev Disabil 2015;120:514-26.
23. Tay J, Widger K, Stremler R. Self-reported experiences of siblings of children with life-threatening conditions: a scoping review. J Child Health Care 2022;26:517-30.
24. Migliorini L, De Piccoli N. Challenging gender perspective in the community to promote well-being and health. J Prev Interv Community 2020;48:121-31.
25. Maladies Diseases Info Services. L’Observatoire resultats et analyses Le parcours de santé et de vie. Available from https://www.maladiesraresinfo.org/s%E2%80%99informer-sur-les-maladies-rares/observatoire-des-maladies-rares.html [Last accessed 3 Jan 2020].
